𝛼SK or SearchD. Western Therapeutics Institute (4576 JP) - August 20, 2026
SUMMARY
- D. Western Therapeutics Institute, Inc. (DWTI, hereafter “the Company”) announced its H1 FY2026/12 results after market close on August 13, 2026.
- Net sales came to JPY 33 mn (-80.9% YoY). In terms of costs, the Company recorded SG&A expenses of JPY 346 mn (- 25.5% YoY), including R&D expenses of JPY 217 mn (-31.7% YoY).
- As a result, the Company recorded an operating loss of JPY 312 mn (loss of JPY 309 mn a year earlier), an ordinary loss of JPY 322 mn (loss of JPY 316 mn), and a net loss attributable to owners of parent (hereafter, net loss) of JPY 323 mn (loss of JPY 316 mn).
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- D. Western Therapeutics Institute (4576 JP) - August 20, 202627 Aug 2026
x